Business News: Sequent Scientific's Albendazole Receives WHO Prequalification, Strengthening Global Health Impact
Mumbai, India - In a significant development for global health, Sequent Scientific Ltd has announced that it has received prequalification (PQ) approval from the World Health Organization (WHO) for its Active Pharmaceutical Ingredient (API) Albendazole. This marks a milestone for the company, which has partnered with Mepro Pharmaceuticals Private Ltd to develop and commercialize the Albendazole chewable formulation, the first of its kind to receive global approval by the WHO PQ.
Albendazole is a critical medication used to combat a variety of parasitic infections, including tapeworm, roundworm, and hookworm infestations, which affect millions worldwide, particularly in low and middle-income countries. The WHO prequalification recognizes Sequent Scientific's commitment to stringent international standards in the production of Albendazole API, ensuring its efficacy, safety, and quality.
"The WHO prequalification approval validates our manufacturing capabilities and reinforces our dedication to providing high-quality, affordable medicines to those in need worldwide," said Rajaram Narayanan, MD and CEO of Sequent Scientific. By leveraging its extensive distribution network and strategic partnerships, the company is poised to make a meaningful impact on health outcomes globally.
This development is expected to bolster Sequent Scientific's position in the global pharmaceutical market, as it continues to focus on delivering life-saving medications that meet the highest international standards. The company's shares ended at ₹157.35, down by ₹14.20, or 9.92% on the BSE, reflecting the market's response to this significant achievement.
With this prequalification, Sequent Scientific is now better equipped to contribute to global health initiatives, potentially saving millions of lives by providing access to a crucial medication for parasitic infections. This approval not only underscores the company's manufacturing prowess but also its role as a key player in the global fight against parasitic diseases.
Post time: Dec-18-2024